(Q73042225)
Statements
Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix (English)
C Lhommé
P Fumoleau
P Fargeot
Y Krakowski
V Dieras
J Chauvergne
P Vennin
P Rebattu
H Roche
J L Misset
M A Lentz
M Van Glabbeke
A Matthieu-Boué
D Mignard
B Chevallier
1 October 1999